Related Experiment Video
Updated: Dec 11, 2025

Author Spotlight: Optimizing iPSC Differentiation for Efficient Production to Generate Kidney Organoids
Published on: September 1, 2023
Differentiating Induced Pluripotent Stem Cells into Renal Cells: A New Approach to Treat Kidney Diseases
Patrícia de Carvalho Ribeiro1, Lucas Felipe Oliveira2,3, Mario Abbud Filho1,4,5
1Laboratory of Immunology and Experimental Transplantation-LITEX, Medical School of Sao Jose do Rio Preto, Sao Jose do Rio Preto, Sao Paulo, Brazil.
Abstract:
Renal disease is a major issue for global public health. Despite some progress in supportive care, the mortality rates among patients with this condition remain alarmingly high. Studies in pursuit of innovative strategies to treat renal diseases, especially stimulating kidney regeneration, have been developed. In this field, stem cell-based therapy has been a promising area. Induced pluripotent stem cell-derived renal cells (iPSC-RCs) represent an interesting source of cells for treating kidney diseases. Advances in regenerative medicine using iPSC-RCs and their application to the kidney are discussed in this review. Furthermore, the way differentiation protocols of induced pluripotent stem cells into renal cells may also be applied for the generation of kidney organoids is also described, contributing to studies in renal development, kidney diseases, and drug toxicity tests. The translation of the differentiation methodologies into animal model studies and the safety and feasibility of renal differentiated cells as a treatment for kidney injury are also highlighted. Although only few studies were published in this field, the results seem promising and support the use of iPSC-RCs as a potential therapy in the future.
Insights
Induced pluripotent stem cell-derived renal cells (iPSC-RCs) show promise for treating kidney diseases and stimulating regeneration. Research explores their application in regenerative medicine, organoid generation, and potential future therapies for kidney injury.
Area of Science:
- Regenerative Medicine
- Stem Cell Biology
- Nephrology
Background:
- Renal disease poses a significant global health challenge with high mortality rates.
- Current supportive care for kidney diseases has limitations, necessitating innovative treatment strategies.
- Stem cell-based therapy is emerging as a promising avenue for kidney regeneration.
Purpose of the Study:
- To review advances in regenerative medicine utilizing induced pluripotent stem cell-derived renal cells (iPSC-RCs) for kidney applications.
- To discuss the generation of kidney organoids from iPSC-RCs for research purposes.
- To highlight the translation of iPSC-RC differentiation into animal models and assess therapeutic potential.
Main Methods:
- Review of current literature on iPSC-RC differentiation and application in kidney disease.
- Exploration of protocols for generating renal cells and kidney organoids from induced pluripotent stem cells.
- Analysis of studies involving animal models and safety assessments of iPSC-RCs.
Main Results:
- iPSC-RCs offer a promising cell source for treating kidney diseases.
- Differentiation protocols enable the generation of kidney organoids for developmental and drug testing studies.
- Early animal model studies suggest potential safety and feasibility for iPSC-RCs in treating kidney injury.
Conclusions:
- iPSC-RCs represent a significant advancement in regenerative medicine for renal diseases.
- The application of iPSC-RCs holds potential for future therapeutic strategies and research tools.
- Further research and clinical translation are warranted to fully realize the potential of iPSC-RCs in nephrology.
More Related Videos
Related Concept Videos
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
iPS Cell Differentiation
EPS and iPS Cells in Disease Research
Stem Cell Culture
Embryonic Stem Cells

